4527N Stock Chart & Stats
$290.00
$0.00(0.00%)
At close: 4:00 PM EDT
$290.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$290.00 - $317.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$61.10B
Enterprise Value$539.70K
Total Cash (Recent Filing)$86.82B
Total Debt (Recent Filing)$60.24B
Price to Earnings (P/E)15.8
Beta0.01
Next Earnings
Aug 06, 2026EPS Estimate
4.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)151.56
Shares Outstanding236,178,310
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.40
Price to Book (P/B)1.80
Price to Sales (P/S)1.58
P/FCF Ratio14.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$314.32Price Target Upside8.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)16.7
Revenue Forecast (FY)$39.21B
Rohto Pharmaceutical Co News
4527N FAQ
What was Rohto Pharmaceutical Co Ltd’s price range in the past 12 months?
Rohto Pharmaceutical Co Ltd lowest stock price was $290.00 and its highest was $317.00 in the past 12 months.
What is Rohto Pharmaceutical Co Ltd’s market cap?
Rohto Pharmaceutical Co Ltd’s market cap is $61.10B.
When is Rohto Pharmaceutical Co Ltd’s upcoming earnings report date?
Rohto Pharmaceutical Co Ltd’s upcoming earnings report date is Aug 06, 2026 which is in 4 days.
How were Rohto Pharmaceutical Co Ltd’s earnings last quarter?
Rohto Pharmaceutical Co Ltd released its earnings results on May 13, 2026. The company reported $2.91 earnings per share for the quarter, missing the consensus estimate of $3.345 by -$0.435.
Is Rohto Pharmaceutical Co Ltd overvalued?
According to Wall Street analysts Rohto Pharmaceutical Co Ltd’s price is currently Undervalued.
Does Rohto Pharmaceutical Co Ltd pay dividends?
Rohto Pharmaceutical Co Ltd does not currently pay dividends.
What is Rohto Pharmaceutical Co Ltd’s EPS estimate?
Rohto Pharmaceutical Co Ltd’s EPS estimate is 4.39.
How many shares outstanding does Rohto Pharmaceutical Co Ltd have?
Rohto Pharmaceutical Co Ltd has 236,178,310 shares outstanding.
What happened to Rohto Pharmaceutical Co Ltd’s price movement after its last earnings report?
Rohto Pharmaceutical Co Ltd reported an EPS of $2.91 in its last earnings report, missing expectations of $3.345. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Rohto Pharmaceutical Co Ltd?
Currently, no hedge funds are holding shares in MX:4527N
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rohto Pharmaceutical Co Ltd
Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global entity engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical goods, beauty products, and nutritional supplements. Their comprehensive product line includes various ophthalmic solutions such as eye drops, contact lens care products, and eye washes. For skincare, they offer facial treatments like cleansers, toners, and creams, in addition to specialized medicated preparations for the skin. The company's offerings also extend to internal medicines, encompassing digestive aids, herbal remedies, and dietary supplements. Furthermore, they supply over-the-counter medications and deliver beauty and health services via dedicated counters. The company rebranded from Yamada Pharmaceutical to Rohto Pharmaceutical Co.,Ltd. in September 1949.
4527N Stock 12 Month Forecast
Average Price Target
$314.32
▲(8.39% Upside)